LATEST NEWS

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti- CTLA4 in an anti-PD1 resistant lung cancer model

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.